Verardi, Lucrezia
 Distribuzione geografica
Continente #
NA - Nord America 257
EU - Europa 182
AS - Asia 57
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 500
Nazione #
US - Stati Uniti d'America 257
SE - Svezia 65
IT - Italia 45
CN - Cina 23
IE - Irlanda 21
SG - Singapore 19
FR - Francia 14
DE - Germania 13
IN - India 10
GB - Regno Unito 5
RU - Federazione Russa 4
CI - Costa d'Avorio 3
FI - Finlandia 3
PL - Polonia 3
BE - Belgio 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
EU - Europa 1
IR - Iran 1
MD - Moldavia 1
MY - Malesia 1
UA - Ucraina 1
Totale 500
Città #
Chandler 92
Ashburn 29
Dublin 21
New York 14
Rome 13
Singapore 10
Bremen 8
Marseille 8
Princeton 8
San Mateo 8
Pune 7
Boston 6
Augusta 5
Moscow 4
Palermo 4
Abidjan 3
Andover 3
Ann Arbor 3
Beijing 3
Fairfield 3
Houston 3
Los Angeles 3
Milan 3
Norwalk 3
Paris 3
Terni 3
Wilmington 3
Brussels 2
Cambridge 2
Cisterna di Latina 2
Helsinki 2
Hong Kong 2
Montemarciano 2
Mumbai 2
Pescara 2
Poggio A Caiano 2
Bern 1
Birmingham 1
Brno 1
Chisinau 1
Dubai 1
Frankfurt am Main 1
Greenwich 1
Haikou 1
Kuala Lumpur 1
Lappeenranta 1
London 1
Olomouc 1
Phoenix 1
Reghin 1
San Francisco 1
Seattle 1
Zellingen 1
Totale 308
Nome #
Sarilumab use in severe SARS-CoV-2 pneumonia 68
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 63
Adult-onset Still's disease following COVID-19 vaccination 61
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 50
An unusual lung involvement in scleroderma: lipoid pneumonia 50
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 48
New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination 44
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 35
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 31
Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic 20
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? 19
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 16
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 7
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement 6
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? 4
Totale 522
Categoria #
all - tutte 3.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 1 1 0 8 4 5 0
2021/202289 2 2 2 12 4 3 2 13 3 10 9 27
2022/2023252 29 33 22 35 13 29 14 21 22 5 11 18
2023/2024161 3 40 4 13 4 27 15 3 2 10 21 19
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 522